An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT trial)

American Heart Journal

Volumn 137, Issue 6, 1999, Pages 1100-1106

  Shapiro, Peter A ^a   Lespérance, François ^b   Frasure Smith, Nancy ^b   O'Connor, Christopher M ^b   Baker, Brian ^b   Jiang, Jan Wei ^b   Dorian, Paul ^b   Harrison, Wilma ^b   Glassman, Alexander H ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ABDOMINAL PAIN; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING TIME; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HEART CONDUCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEMOSTASIS; HUMAN; MALE; MOOD; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THORAX PAIN; VERTIGO;

EID: 0343593736     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70369-8     Document Type: Article

References (50)

1. Malzberg B. Mortality among patients with involution melancholia. Am J Psychiatry 1937;93:1231-38.
2. Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976;33:1029-37.
3. Black DW, Warrack G, Winokur G. Excess mortality among psychiatric patients: the Iowa record-linkage study. JAMA 1985;253:58-61.
4. Weeke A, Vaeth M. Excess mortality of bipolar and unipolar manic-depressive patients. J Affect Disord 1986;11:227-34.
5. Murphy JM. Depression in the community: findings from the Stirling County Study. Can J Psychiatry 1990;35:390-6.
6. Ahern DK, Gorkin L, Anderson JL, et al, for the CAPS Investigators. Biobehavioral variables and mortality or cardiac arrest in the cardiac arrhythmia: pilot study (CAPS). Am J Cardiol 1990;66:59-62.
7. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285-94.
8. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl 1994;377:77-82.
9. Everson SA, Goldberg DE, Kaplan GA, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996;58:113-21.
10. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-80.
11. Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996;94:3123-9.
12. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
13. Ladwig KH, Kieser M, Konig J, et al. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J 1991;12:959-64.
14. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
15. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis following myocardial infarction. Circulation 1995;91:999-1005.
16. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613-7.
17. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Heath Psychol 1995;14:388-98.
18. Roose SP, Glassman AH. Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. J Clin Psychiatry 1989;50:S1-18.
19. Giardina EG, Barnard T, Johnson L, et al. The antiarrhythmic effect of nortriptyline in cardiac patients with premature ventricular depolarizations. J Am Coll Cardiol 1986;7:1363-9.
20. CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
21. Echt DS, Liebson PR, Mitchelle LB, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med 1991;324:781-8.
22. CAST II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
23. Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. Circulation 1991;84:1977-83.
24. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993;270:1589-95.
25. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA 1993;269:2673-5.
26. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998;155:660-5.
27. Gram LF. Fluoxetine. N Engl J Med 1994;331:1354-61.
28. Ellison JM, Milofsky JE, Ely E. Fluoxetine induced bradycardia and syncope in 2 patients. J Clin Psychiatry 1990;51:385-6.
29. Feder R. Bradycardia and syncope induced by fluoxetine. J Clin Psychiatry 1991;52:138-9.
30. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
31. Berk M, Jacobson BF, Hurly E. Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry 1995;56:14-6.
32. Pollock BG, Laghrissi-Thode F, Wagner WR, et al. Increased platelet factor 4 and beta-thromboglobulin in depressed patients with ischemic heart disease. Scientific Abstracts of the 34th Annual Meeting of the American College of Neuropsychopharmacology. San Juan: 1995. p. 121.
33. Laghrissi-Thode F, Wagner WR, Pollack BG, et al. Elevated platelet factor 4 and beta-thromboglogulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-5.
34. Robins LN, Helzer JE, Criughan J, et al. National Institute of Mental Health diagnostic interview schedule: its history, characteristics, and validity. Arch Gen Psychiatry 1981;38:381-9.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
36. Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
37. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV axis I disorders: non-patient edition (SCID-I/NP, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1994.
38. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
39. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, Md: USPHS; 1976.
40. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986;255:357-60.
41. Davis BR, Furberg CD, Williams CB. Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial. Clin Pharmacol Ther 1987;41:611-5.
42. Paykel ES, Fleminge RR, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharm 1982;2:14-39.
43. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58:99-110.
44. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease, I: treatments following myocardial infarction. JAMA 1988;260:2088-93.
45. Walley T, Pirmohamed M, Proudlove C, et al. Interaction of metoprolol and fluoxetine. Lancet 1993;341:967-8.
46. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
47. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
48. Forrester AW, Lipsey JR, Teitelbaum ML, et al. Depression following myocardial infarction. Int J Psychiatry Med 1992;22:33-46.
49. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785-9.
50. Ladwig KH, Roll G, Breithardt G, et al. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994;343:20-3.